Left ventricular dysfunction assessed by speckle‐tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular …

KH Yiu, AA Schouffoer, NA Marsan… - Arthritis & …, 2011 - Wiley Online Library
Objective Systemic sclerosis (SSc) is a connective tissue disease characterized by vascular
inflammation and fibrosis. Visceral involvement, including cardiac manifestations, can lead …

Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific …

…, JA Bakker, HPC Schippers, AA Schouffoer… - …, 2017 - academic.oup.com
Objective. To evaluate the prevalence of anti–extractable nuclear antigen (anti-ENA)
antibodies in Dutch SSc patients and the predictive power of the combination of specific anti-ENA …

Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review

LM Willems, JE Vriezekolk, AA Schouffoer… - Arthritis care & …, 2015 - Wiley Online Library
Objective To systematically and comprehensively document the effectiveness of nonpharmacologic
interventions on physical functioning and psychological well‐being in patients with …

Rituximab in early systemic sclerosis

…, J Meijs, AL Dorjée, NA Marsan, A Schouffoer… - RMD open, 2017 - rmdopen.bmj.com
Objectives (1) Hypothesis testing of the potency of rituximab (RTX) in preventing fibrotic
complications and (2) assessing acceptability and feasibility of RTX in early systemic sclerosis (…

Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered …

…, J Pope, F Rannou, TSR Reyna, AA Schouffoer… - Journal of …, 2020 - Elsevier
Introduction No studies have reported mental health symptom comparisons prior to and
during COVID-19 in vulnerable medical populations. Objective To compare anxiety and …

Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis

J Meijs, AA Schouffoer, NA Marsan, LJM Kroft… - RMD open, 2016 - rmdopen.bmj.com
Objectives To determine the outcomes, including number of medical interventions and
initiation of immunosuppressive treatment of a standardised, comprehensive, diagnostic care …

Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a phase 3 randomized trial in diffuse cutaneous systemic sclerosis

…, JB Jun, JH Ju, V Dalm, AA Schouffoer… - Arthritis & …, 2023 - Wiley Online Library
Objective This phase 3 study was undertaken to investigate the efficacy and safety of
lenabasum, a cannabinoid type 2 receptor agonist, in patients with diffuse cutaneous systemic …

[HTML][HTML] Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis

AA Schouffoer, EJM Zirkzee, SM Henquet… - Clinical …, 2011 - Springer
This study aims to examine the needs and preferences regarding the delivery of health care
services and information provision and their determinants in patients with systemic sclerosis …

[HTML][HTML] Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 …

…, F Rannou, TSR Reyna, AA Schouffoer… - Journal of …, 2020 - Elsevier
Objective Contagious disease outbreaks and related restrictions can lead to negative
psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical …

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a …

…, L Kroft, B Geurts, M Snoeren, A Schouffoer… - Annals of the …, 2020 - ard.bmj.com
Background Autologous haematopoietic stem cell transplantation (HSCT) improves survival
in systemic sclerosis (SSc) with poor prognosis, but is hampered by treatment-related …